ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,639, issued on June 30, was assigned to ShanghaiTech University (Shanghai).

"Anti-CXCR2 antibodies and uses thereof" was invented by Guang Yang (Shanghai), Xiaojie Shi (Shanghai) and Richard Lerner (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are anti-CXCR2 antibodies and antigen-binding fragments thereof. The antibodies or fragments thereof specifically bind to N-terminal, extracellular domain of the CXCR2 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 2, a VH CDR3 of SEQ ID NO: 3, or any one of SQ ID NO: 7-14, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of S...